Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

Summary: New research reveals how a tiny chemical mark on RNA helps wire the brain during development. Scientists discovered ...

Scientists have discovered Sukunaarchaeum mirabile, a unique archaeon residing within marine plankton, challenging traditional definitions of life. Th ...

A team of researchers at NYU Abu Dhabi has uncovered a key mechanism that helps shape how our brains are wired, and what can ...

Sabic to close UK cracker, plastics recycler Novoloop raises funds, Kymera strikes molecular glue deal, and more ...

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.

Researchers discovered a previously unknown function of RNA, potentially opening the door to new ways to treat cancer and ...

The acquisition will expand AbbVie's exploration of in vivo CAR-T therapy, an ambitious approach that could sidestep some of ...

News & Views Published: August 2009 Kill the messenger: bacterial antisense RNA promotes mRNA decay E Gerhart H Wagner Nature Structural & Molecular Biology 16, 804–806 (2009) Cite this article ...

Explore the booming Flu RNA Vaccines Market, forecasted to grow from USD 2.78 billion in 2025 to USD 5.95 billion by 2032 at a CAGR of 11.5%. Driven by mRNA advancements, the market is crucial for ...